Intermittent Electrical Stimulation for Pressure Sores
Trial Summary
What is the purpose of this trial?
Multicentered randomized controlled study with adaptive design to evaluate if Intermittent Electrical Stimulation (IES) decreases progression and facilitates healing of pressure injuries for patients with, sacral / ischial pressure injuries.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Intermittent Electrical Stimulation (IES) for pressure sores?
A feasibility study found that Intermittent Electrical Stimulation (IES) was safe and easy to use in an intensive care setting, with no pressure sores developing in participants during the study. This suggests that IES could potentially help prevent bedsores, although more research is needed to confirm its effectiveness.12345
Is intermittent electrical stimulation safe for humans?
How does the treatment Intermittent Electrical Stimulation (IES) for pressure sores differ from other treatments?
Intermittent Electrical Stimulation (IES) is unique because it uses electrical currents to stimulate muscle contractions, which helps redistribute pressure and prevent pressure sores, especially in immobile patients. Unlike conventional methods that rely on pressure relief through repositioning, IES actively engages muscles to reduce pressure on vulnerable areas, making it a novel approach for preventing deep tissue injuries.148910
Research Team
Chase Donaldson, MD
Principal Investigator
The Cleveland Clinic
Andrea Kurz, MD
Principal Investigator
The Cleveland Clinic
Eligibility Criteria
This trial is for patients with new or existing stage 1 or 2 pressure ulcers near the tailbone or hip area, in both ICU and non-ICU settings. Participants must be able to consent, or have someone who can consent for them. It's not for those with certain fractures, muscle breakdown (rhabdomyolysis), heart device implants like pacemakers, skin issues that prevent electrode use on the buttocks, or a BMI over 40.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the IES device in addition to the standard of care or the standard of care alone. Treatment continues from randomization to discharge, death, or a minimum of 30 days.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data collection continuing for up to 30 days in non-ICU environments or longer if in ICU.
Treatment Details
Interventions
- Intermittent Electrical Stimulation (IES)
Intermittent Electrical Stimulation (IES) is already approved in United States, European Union, Canada for the following indications:
- Pressure injuries
- Diabetic foot ulcers
- Wound healing
- Pressure injuries
- Diabetic foot ulcers
- Wound healing
- Pressure injuries
- Diabetic foot ulcers
- Wound healing
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor